Literature DB >> 10812460

[Prevalence of diabetes in acromegaly and Cushing syndrome].

H Biering1, G Knappe, H Gerl, H Lochs.   

Abstract

In a retrospective study glucose metabolism was investigated in 206 patients with acromegaly and 131 patients with Cushing's disease. 40.5% of the patients with hypersomatotropism and 32.0% of the patients with hypercortisolism suffered from overt diabetes mellitus. Impaired glucose tolerance was present prior to therapy in 28.2% and 30.6% of the patients, respectively. In acromegaly the incidence of overt diabetes mellitus was higher in women than in men, but no difference existed in the distribution of impaired glucose tolerance between both sexes. No correlation was found between growth hormone levels and occurrence of diabetes. In acromegaly and Cushing's disease overt diabetes increased with advanced age. Diabetes mellitus occurred independently from the etiology of hypercortisolism.

Entities:  

Mesh:

Year:  2000        PMID: 10812460     DOI: 10.1046/j.1563-2571.2000.200106.x

Source DB:  PubMed          Journal:  Acta Med Austriaca        ISSN: 0303-8173


  25 in total

Review 1.  Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.

Authors:  M G Baroni; F Giorgino; V Pezzino; C Scaroni; A Avogaro
Journal:  J Endocrinol Invest       Date:  2015-12-30       Impact factor: 4.256

2.  Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide.

Authors:  Elisabeth Couture; Vanina Bongard; Jean-Christophe Maiza; Antoine Bennet; Philippe Caron
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

Review 3.  Glucose metabolism in Cushing's syndrome.

Authors:  Anu Sharma; Adrian Vella
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-06       Impact factor: 3.243

4.  Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population.

Authors:  Pedro Weslley Rosario
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

5.  Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism.

Authors:  Ana Laura Espinosa-de-los-Monteros; Baldomero González; Guadalupe Vargas; Ernesto Sosa; Moisés Mercado
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

Review 6.  Acromegaly in the elderly patients.

Authors:  Maria Rosaria Ambrosio; Irene Gagliardi; Sabrina Chiloiro; Ana Gonçalves Ferreira; Marta Bondanelli; Antonella Giampietro; Antonio Bianchi; Laura De Marinis; Maria Fleseriu; Maria Chiara Zatelli
Journal:  Endocrine       Date:  2020-02-14       Impact factor: 3.633

7.  Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas.

Authors:  Beverly Mk Biller; Annamaria Colao; Stephan Petersenn; Vivien S Bonert; Marco Boscaro
Journal:  BMC Endocr Disord       Date:  2010-05-17       Impact factor: 2.763

8.  Treatment of Cushing disease: overview and recent findings.

Authors:  Tatiana Mancini; Teresa Porcelli; Andrea Giustina
Journal:  Ther Clin Risk Manag       Date:  2010-10-21       Impact factor: 2.423

Review 9.  Medical consequences of acromegaly: what are the effects of biochemical control?

Authors:  Annamaria Colao; Renata S Auriemma; Rosario Pivonello; Mariano Galdiero; Gaetano Lombardi
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

10.  Diagnosis and treatment of acromegaly complications.

Authors:  A Giustina; F F Casanueva; F Cavagnini; P Chanson; D Clemmons; L A Frohman; R Gaillard; K Ho; P Jaquet; D L Kleinberg; S W J Lamberts; G Lombardi; M Sheppard; C J Strasburger; M L Vance; J A H Wass; S Melmed
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.